Stocks making the biggest moves premarket: Disney, Home Depot, Nvidia & more
Coherent, Applied Optoelectronics, and Lumentum shares rose 11%, 8.6%, and 5.6% respectively, following a Reuters report on potential U.S. restrictions on Chinese data center equipment. Sellas Life Sciences shares gained over 7% after positive trial results for its cancer vaccine. Nvidia shares rose 1% ahead of earnings, despite a 25% stake reduction in Intel. Home Depot shares fell 2% with a CEO transition.
How this was made

The 30-second read
Why it matters
Traders can use the article to separate policy-driven momentum in photonics/data-center names from idiosyncratic catalysts in Disney, Home Depot, Nvidia/Intel, and Sellas.
Market read
The dominant tradable thread is policy-driven upside momentum for photonics/data-center infrastructure, while the rest are discrete stock catalysts (earnings beat, CEO change, pivotal trial, and Nvidia-Intel stake disclosure).
What to watch
For Nvidia and Intel, the stake trim could be portfolio-management rather than a fundamental view; for biotech, the market may still discount the timeline to confirmatory/regulatory milestones.
Background
The piece is a premarket movers roundup citing a Reuters report on planned US restrictions on Chinese data center equipment imports, plus company-specific earnings, trial, and executive-transition updates.
Ticker impact
Nvidia disclosed it trimmed its Intel stake by 25% in the quarter ended Sept. 30, selling nearly $5.5B and reducing its Intel holding.
Shares may face mixed pressure, with some support from the pre-earnings bid but offset by concerns about the Intel stake reduction.
The article provides a concrete regulatory-filing disclosure (stake trim) plus separate context on CEO resignation fallout and an earnings catalyst, which can pull sentiment in different directions.
Intel shares slid after Nvidia disclosed it cut its stake to 161 million shares from 215 million, lowering Nvidia’s holding.
Intel may remain under pressure as traders interpret the stake trim as reduced confidence or strategic de-emphasis.
The article explicitly links Intel’s move to Nvidia’s stake reduction, making the read-across immediate even without additional Intel-specific fundamentals.
Disney reported fiscal fourth-quarter results that beat Street expectations and guided cost cuts targeting $3B by fiscal 2029.
Shares likely hold firmer tone as the market digests the beat and the $3B cost-cut plan.
The article includes specific EPS/revenue beat figures versus LSEG expectations and a quantified cost-cut target, both direct drivers of near-term repricing.
Home Depot shares fell nearly 2% after announcing Richard McPhail will take over as CEO from Ted Decker next week.
Shares may remain range-bound to slightly weak until investors assess the new CEO’s strategy and execution.
The article ties the premarket drop directly to the CEO change, but provides limited detail on strategy, limiting conviction on direction beyond the initial reaction.
Coherent shares rallied 11% after the Reuters report that the Trump administration plans to block imports of Chinese data center equipment.
Shares likely see continued bid while traders price in reduced Chinese equipment competition and higher domestic/ally demand.
The article reports the move and the macro policy catalyst but does not specify Coherent’s direct revenue exposure or product linkage to the blocked equipment.
Applied Optoelectronics shares rose 8.6% following the Reuters report of a planned ban on Chinese data center equipment imports.
Shares may stay supported as the market extends the policy read-through to photonics names.
The catalyst is clear, but the article does not detail Applied Optoelectronics’ specific affected product lines or customer contracts.
Lumentum shares gained 5.6% after the Reuters report that the Trump administration plans to block imports of Chinese data center equipment.
Shares likely track the group’s momentum unless policy details narrow or implementation timing changes.
The article provides the price move and the policy headline but lacks company-specific linkage to the blocked equipment category.
Sellas Life Sciences rose more than 7% after reporting positive Phase 3 trial results for its immunotherapeutic cancer vaccine, meeting the primary endpoint.
Shares likely see continued upside momentum as traders focus on the magnitude of survival benefit and next regulatory steps.
The article includes pivotal trial success with a quantified risk reduction and no new safety risks, which is typically material for biotech valuation.
Market effects
A potential import block on Chinese data center equipment is a direct read-through catalyst for photonics and data-center infrastructure supply chains.
US policy-driven trade restrictions can shift demand toward non-Chinese suppliers, affecting global component pricing and order timing.
If implemented, the policy could accelerate decoupling trends in data-center hardware and optics across major markets.
Counterpoint
The photonics rallies may over-discount the policy’s scope and timing; without clarity on which equipment categories are blocked, some moves could fade quickly.
Key entities
- governmentTrump administration
Reportedly plans to block imports of Chinese data center equipment, driving a group rally in photonics names.
- companyNvidia
Disclosed a reduction in its Intel stake and is approaching earnings amid CEO resignation fallout.
- companyDisney
Reported fiscal Q4 results that beat expectations and announced a $3B cost-cut target by fiscal 2029.
- companyHome Depot
Announced a CEO transition effective next week, with Decker remaining as chairman.
- companySellas Life Sciences
Reported positive Phase 3 trial results meeting the primary endpoint for overall survival.

